These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 556281)

  • 1. The study of the immune responses in patients with uncomplicated urinary schistosomiasis.
    El-Hawey AM; Abdel-Wahab KS; Saber MA
    J Egypt Med Assoc; 1978; 61(3-4):253-62. PubMed ID: 556281
    [No Abstract]   [Full Text] [Related]  

  • 2. Niridazole, a potent long-acting suppressant of cellular hypersensitivity. III. Minimal suppression of antibody responses.
    Pelley RP; Pelley RJ; Stavitsky AB; Mahmoud AA; Warren KS
    J Immunol; 1975 Dec; 115(6):1477-82. PubMed ID: 1184961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgE serum levels in urinary schistosomiasis.
    Nuti M; Rasi G; Simoni L; Bonini S
    Tropenmed Parasitol; 1979 Sep; 30(3):383-6. PubMed ID: 543003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some immunological findings in patients with hydatidosis or schistosomiasis.
    Nassir JK; Thewaini AJ
    Ann Trop Med Parasitol; 1982 Feb; 76(1):71-6. PubMed ID: 6979316
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole.
    Webster LT; Butterworth AE; Mahmoud AA; Mngola EN; Warren KS
    N Engl J Med; 1975 May; 292(22):1144-7. PubMed ID: 1124104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immune assay in children with Schistosoma haematobium infection and the effect of niridazole therapy.
    Abdel-Salam E; Higashi GI; Kamal KA; Ishaac S
    Trans R Soc Trop Med Hyg; 1981; 75(2):207-14. PubMed ID: 7303134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a modified complement fixation test for schistosomiasis.
    Tanaka H; Dennis DT; Kean BH; Matsuda H; Sasa M
    Jpn J Exp Med; 1972 Dec; 42(6):537-42. PubMed ID: 4540905
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum antibody and eosinophil changes after treatment of human Manson's schistosomiasis with niridazole or hycanthone.
    da Silva LC; Camargo ME; Hoshino S; Gunji J; Lopes JD; Chamone DF; Martinez JO; Ferri RG; Rothstein W; da Silva GR; Ceneviva AC; Cardoso EJ
    Rev Inst Med Trop Sao Paulo; 1971; 13(2):121-30. PubMed ID: 5005734
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of treatment with different antibilharzial drugs on renal functions in urinary schistosomiasis.
    el-Zayadi AM; Shoeb SM; Sabour MS; Basmy K
    Tropenmed Parasitol; 1974 Jun; 25(2):147-52. PubMed ID: 4418544
    [No Abstract]   [Full Text] [Related]  

  • 10. Surface hepatitis B antigen and urinary schistosomiasis.
    Nuti M; Elmi SA; Alario C; Palermo P
    Trans R Soc Trop Med Hyg; 1979; 73(3):352-3. PubMed ID: 473337
    [No Abstract]   [Full Text] [Related]  

  • 11. A trial of the suppression of infection of Bulinus snails during ambilhar (niridazole) therapy of bilharziasis.
    El-Gindy MS; Mousa AH; Roushdy MZ
    Egypt J Bilharz; 1974; 1(2):261-77. PubMed ID: 4471064
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of a molluscicide in conjunction with chemotherapy to control Schistosoma haematobium at the Barombi Lake foci in Cameroon. II. Urinary examination methods, the use of niridazole to attack the parasite in man, and the effect on transmission from man to snail.
    Duke BO; Moore PJ
    Tropenmed Parasitol; 1976 Dec; 27(4):489-504. PubMed ID: 1006804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic parameters of children with urinary tract infection: effects of trimethoprim-sulfamethoxazole.
    Wolfish NM; Wassef N; Gonzalez H; Acharya C
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):76-9. PubMed ID: 1079471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Schistosoma haematobium infection and urinary tract infection among children in South Eastern, Nigeria.
    Eyong ME; Ikepeme EE; Ekanem EE
    Niger Postgrad Med J; 2008 Jun; 15(2):89-93. PubMed ID: 18575479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental Escherichia coli 06 infection in mice. II. Protective factors of immunity after immunosuppression.
    Ahlstedt S
    Scand J Infect Dis Suppl; 1980; Suppl 24():216-9. PubMed ID: 7010558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of in vitro lymphocyte proliferation in patients with Schistosomiasis haematobium, Schistosomiasis mansoni and mixed infections.
    Feldmeier H; Kern P; Niel G
    Tropenmed Parasitol; 1981 Dec; 32(4):237-42. PubMed ID: 7345689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum immuno-globulins in children with bilharzial infection.
    Soliman MH; el-Waseef A; Onbor AA; el-Kashlan KM
    J Hyg Epidemiol Microbiol Immunol; 1973 Mar; 17(3):346-53. PubMed ID: 4200698
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors that modify the cellular-immune response in patients infected by Schistosoma mansoni.
    Rocklin RE; Brown AP; Warren KS; Pelley RP; Houba V; Siongok TK; Ouma J; Sturrock RF; Butterworth AE
    J Immunol; 1980 Nov; 125(5):1916-23. PubMed ID: 6448892
    [No Abstract]   [Full Text] [Related]  

  • 19. [Urinary infections caused by Salmonella typhi and Schistosoma haematobium].
    Kernbaum S; Leclerc P; Bastin R
    Nouv Presse Med; 1979 Jan; 8(5):366. PubMed ID: 554097
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of Schistosoma mansoni and Schistosoma haematobium in Kitui District, Kenya.
    Ouma JH; Waithaka F
    East Afr Med J; 1978 Feb; 55(2):54-60. PubMed ID: 668604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.